TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT00197561

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Taken orally once per day from randomization through delivery and through the first 6 months after delivery.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Selenium
Description: 200 ug of selenomethionine taken orally once per day from randomization through delivery and for the first 6 months after delivery
Study: NCT01953731

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib
Description: In period 1, patients will receive a single 125mg oral dose of palbociclib alone. Subjects will undergo palbociclib pharmacokinetic sampling at prespecified time points up to 120 hours post palbociclib dose.~In period 2, subjects will receive 12 daily oral doses of 600mg of rifampin and a single 125mg oral dose of palbociclib on day 8. Subjects will undergo palbociclib pharmacokinetic sampling at prespecified time points up to 120 hours post palbociclib dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifampin
Description: In period 2, subjects will receive 12 daily oral doses of 600mg of rifampin and a single 125mg oral dose of palbociclib on day 8. Subjects will undergo palbociclib pharmacokinetic sampling at prespecified time points up to 120 hours post palbociclib dose.
Study: NCT01098058

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CBT plus treatment as usual
Description: 16 one-hour therapy sessions taking place over 42 weeks in addition to usual medical follow-up appointments

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual
Description: Treatment as usual appointments at the Adult ADHD Service - typically one 30-minute appointment every three to six months
Study: NCT03080402

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mechanical Perturbation Training
Description: The training program will consist of three stages and subjects will progress through each neuromuscular training stage.The training will consist of double- to single-limb movements with progression of jumping, hopping, and pivoting maneuvers on the perturbation device with an emphasis on proper technique and landing. The initial four sessions will focus on primarily on jumping and hopping maneuvers on double- and single-limb in the sagittal plane. The intermediate four sessions will incorporate additional medial and lateral maneuvers with the plyometric tasks. The final four sessions will incorporate rotational and pivoting activities with the maneuvers. The resultant protocol has been derived and optimized from previous published research studies and prevention techniques.
Study: NCT00004317

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Leucovorin calcium
Description: See arm descriptions

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Leucovorin calcium
Description: See arm descriptions
Study: NCT03474952

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: remote ischemic preconditioning (RIPC)
Description: remote ischemic preconditioning consists of 4 cycles of 5-min ischemia and subsequent 5-min reperfusion using pneumatic cuff applied to upper arm

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: sham-RIPC
Description: ischemia pressure less than 10 mmHg (sham-RIPC)
Study: NCT02416167

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FYU-981

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FYU-981

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FYU-981
Study: NCT03707405

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Ride-On Cars Training with Different Postures
Description: All programs will include 120 minutes/per session, 2 sessions/per week. All participants will continue their regular therapy during the whole study. The treatment strategy of ROC training with different postures will be based on the exploratory learning which focuses on providing opportunities to the participants to explore environmental properties with various motor patterns during the intervention.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Ride-On Cars Training with Different Postures
Description: All programs will include 120 minutes/per session, 2 sessions/per week. All participants will continue their regular therapy during the whole study. The treatment strategy of ROC training with different postures will be based on the exploratory learning which focuses on providing opportunities to the participants to explore environmental properties with various motor patterns during the intervention.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Ride-On Cars Training with Different Postures
Description: All programs will include 120 minutes/per session, 2 sessions/per week. All participants will continue their regular therapy during the whole study. The treatment strategy of ROC training with different postures will be based on the exploratory learning which focuses on providing opportunities to the participants to explore environmental properties with various motor patterns during the intervention.
Study: NCT01796678

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Arginine

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Saline or Sugar pill was given as placebo
Study: NCT02416167

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FYU-981

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT01244516

Intervention type: DEVICE
Group type: OTHER
Intervention: galyfilcon A, BC 8.30
Description: galyfilcon A, BC 8.30 soft contact lens

Intervention type: DEVICE
Group type: OTHER
Intervention: lotrafilcon B, BC 8.60
Description: lotrafilcon B, BC 8.60 soft contact lens

Intervention type: DEVICE
Group type: OTHER
Intervention: comfilcon A, BC 8.60
Description: comfilcon A, BC 8.60 soft contact lens
Study: NCT02660047

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Liraglutide
Description: Drug: Liraglutide~Preparation and labelling of Investigational Medicinal Product:~Liraglutide will be packed and labeled by Novo Nordisk A/S and provided in non-subject specific boxes. Labeling will be in accordance with Annex 13, local law and trial requirements. The examples of labels are not readily available, but will be supplied when received from Novo Nordisk.~Drug accountability:~Drug accountability will be cared for by the Department of Clinical Pharmacy of the LUMC. The trial product will be dispensed to each subject as required according to treatment group by the clinical pharmacist. No trial product will be dispensed to any person not enrolled in the trial.
Study: NCT00004317

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyrimethamine
Description: See arm descriptions

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyrimethamine
Description: See arm descriptions

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Spiramycin
Description: Spiramycin is administered before the fetal diagnosis is made.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Spiramycin
Description: Spiramycin is administered before the fetal diagnosis is made.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sulfadiazine
Description: See arm descriptions

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sulfadiazine
Description: See arm descriptions
Study: NCT01182077

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASP015K
Description: Oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASP015K
Description: Oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: Oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: Oral
Study: NCT01723891

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Surfolase capsule

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Surfolase capsule

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HT-002-01

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HT-002-01
Study: NCT03123120

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Spesolimab
Description: 12 weeks treatment

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 12 weeks treatment
Study: NCT02353312

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Kuvan
Description: Kuvan® (sapropterin dihydrochloride) will be initiated at 10mg/kg/day with meals for one week. After telephone contact on day 7, assuming no adverse effects are noted, the patient will be instructed to increase their daily dose to 20mg/kg/day with meals for the remainder of the 3 months.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Kuvan
Description: Kuvan® (sapropterin dihydrochloride) will be initiated at 10mg/kg/day with meals for one week. After telephone contact on day 7, assuming no adverse effects are noted, the patient will be instructed to increase their daily dose to 20mg/kg/day with meals for the remainder of the 3 months.
Study: NCT02417454

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: ProbioStick
Description: One sachet daily, without or without meals (3 x 10\^9 CFU per sachet)~(Lactobacillus helveticus R0052 and Bifidobacterium longum subsp. longum R0175)
Study: NCT02187939

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Summer science wellness program emphasizing health education pertaining to nutrition, physical activity, and healthy lifestyle.
Description: The enhanced virtual world education (GROOVE+) will be compared to conventional approach (GROOVE). Each program is Monday-Friday, 9:30-3:30, for 3 weeks in the summer.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Summer science wellness program emphasizing health education pertaining to nutrition, physical activity, and healthy lifestyle.
Description: The enhanced virtual world education (GROOVE+) will be compared to conventional approach (GROOVE). Each program is Monday-Friday, 9:30-3:30, for 3 weeks in the summer.
Study: NCT02263118

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Uni-directional SMS
Description: Exposure to breastfeeding promoting SMSs

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Uni-directional SMS
Description: Exposure to breastfeeding promoting SMSs

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Uni-directional SMS
Description: Exposure to breastfeeding promoting SMSs

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Feature phone
Description: Participants were given a feature phone.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Feature phone
Description: Participants were given a feature phone.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Feature phone
Description: Participants were given a feature phone.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Feature phone
Description: Participants were given a feature phone.
Study: NCT02417454

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: One sachet daily, without or without meals (0 CFU per sachet)
Study: NCT02263118

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual communities
Description: Exposure to virtual community communication via SMS

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual communities
Description: Exposure to virtual community communication via SMS

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hybrid setup
Description: Exposure to virtual community and access to communications with health professional via SMS
Study: NCT02437175

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: ENDO 1/ENDO 2
Description: NUTRI ENDO 1 (1 sequence of 10 tablets on the morning) and NUTRI ENDO 2 ( sequence of 10 tablets at the evening), daily, during 120 days.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo: 1 sequence of 10 tablets on the morning and 1 sequence of 10 tablets at the evening, daily, during 120 days.
Study: NCT00745459

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NPO-11
Description: 20 mL NPO-11
Study: NCT01062100

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: nuclear breast imaging using MBI Gamma camera
Description: nuclear breast imaging using MBI Gamma camera in addition to MRI
Study: NCT03713515

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ALTA
Description: The study will involve each site starting with the usual care phase, followed by a period of 6 months during which practice facilitators will conduct the pre-implementation evaluation (e.g., workflow analysis, environmental scan), refine the practice facilitation strategies that will be used in the implementation phase, and train staff in the Advancing Medication Adherence for Latinos with Hypertension through a Team-based Care Approach (ALTA) intervention model. ALTA is an efficacious systems-level intervention designed to help patients improve their ability to take their high blood pressure medications and control their blood pressure. Practices and the Project ALTA team will work together to implement the ALTA model into routine care to improve blood pressure control and medication adherence in Latinx patients.
Study: NCT02439801

Intervention type: PROCEDURE
Intervention: PEEP 0
Description: 0 cmH2O positive end expiratory pressure

Intervention type: PROCEDURE
Intervention: PEEP 0
Description: 0 cmH2O positive end expiratory pressure

Intervention type: PROCEDURE
Intervention: PEEP 0
Description: 0 cmH2O positive end expiratory pressure

Intervention type: PROCEDURE
Intervention: PEEP 5
Description: 5 cmH2O positive end expiratory pressure

Intervention type: PROCEDURE
Intervention: PEEP 5
Description: 5 cmH2O positive end expiratory pressure

Intervention type: PROCEDURE
Intervention: PEEP 5
Description: 5 cmH2O positive end expiratory pressure

Intervention type: PROCEDURE
Intervention: PEEP 8
Description: 8 cmH2O positive end expiratory pressure

Intervention type: PROCEDURE
Intervention: PEEP 8
Description: 8 cmH2O positive end expiratory pressure

Intervention type: PROCEDURE
Intervention: PEEP 8
Description: 8 cmH2O positive end expiratory pressure
Study: NCT03506776

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Education and Thermometer Group
Description: The education will be provided in video format utilizing the Canadian Association of Wound Care (CAWC) diabetic foot management YouTube video and one-on-one teaching. Participants will be provided with an inspection mirror with an extendable handle to assist with visualizing the bottom of the feet and a pedometer to measure daily activity. One-on-one teaching with the thermometer will be provided. Participants will be given a handout for reference on using the thermometer. The foot model will be marked with a zigzag pattern on the plantar surface to illustrate the path that should be used when measuring temperature. The support person will be included in the teaching if he/she will be assisting the participant to obtain temperature readings.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Education Only Group
Description: The education will be provided in video format utilizing the Canadian Association of Wound Care (CAWC) diabetic foot management YouTube video and one-on-one teaching. Participants will be provided with an inspection mirror with an extendable handle to assist with visualizing the bottom of the feet and a pedometer to measure daily activity.
Study: NCT04473339

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: CRS+HIPEC
Description: Patients will undergo only CRS, HIPEC and IVCT.Patients will receive standard platinum-based combination doublet chemotherapy for 6-8 cycles after CRS and then followed by maintenance therapy.~A single drug lobaplatin(30mg/m2)will be administered in normal saline via HIPEC and it will be continued for 60 minutes in the hyperthermic phase (41°C-43°C). HIPEC will be performed at the 1st, 3rd and 5th day after CRS. The intravenous chemotherapy(IVCT) will start from 7th-14th day after CRS.
Study: NCT04112693

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Esophageal biopsies during Peroral Endoscopic Myotomy (POEM)
Description: In total, 14 biopsies are performed with a pediatric biopsy forceps belonging to the study center: 3 biopsies at 3-6 cm above cardia, contralaterally from POEM, of which 2 are placed in nitrogen and 1 in formol for histopathological analysis; 3 biopsies at the cardia, contralaterally from POEM, of which 2 are placed in nitrogen and 1 in formol for histopathological analysis; 4 biopsies of the muscularis propria (exposed during POEM) at 3-6 cm above cardia, of which 3 are placed in nitrogen and 1 in formol for histopathological analysis; 4 biopsies of the muscularis propria at the cardia, of which 3 are placed in nitrogen and 1 in formol for histopathological analysis; The biopsies intended for histopathological analysis will be analyzed in FFOCT before histopathological analysis. The FFOCT analysis take place for the patient inclued after than 10 november 2020.~The biopsies are taken by the gastroenterologist who performs the POEM and is assisted by an endoscopy-specialized nurse.
Study: NCT04473339

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: CRS+HIPEC
Description: Patients will undergo only CRS, HIPEC and IVCT.Patients will receive standard platinum-based combination doublet chemotherapy for 6-8 cycles after CRS and then followed by maintenance therapy.~A single drug lobaplatin(30mg/m2)will be administered in normal saline via HIPEC and it will be continued for 60 minutes in the hyperthermic phase (41°C-43°C). HIPEC will be performed at the 1st, 3rd and 5th day after CRS. The intravenous chemotherapy(IVCT) will start from 7th-14th day after CRS.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: CRS alone
Description: Patients will undergo only CRS and IVCT.Patients will receive standard platinum-based combination doublet chemotherapy for 6-8 cycles after CRS and then followed by maintenance therapy.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: CRS alone
Description: Patients will undergo only CRS and IVCT.Patients will receive standard platinum-based combination doublet chemotherapy for 6-8 cycles after CRS and then followed by maintenance therapy.
Study: NCT00956709

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: levobupivacaïne 0,5 %
Description: 20mL de levobupivacaïne 0,5 % 20mL de ropivacaïne 0,5 %

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ropivacaïne 0,5 %
Description: 20mL de ropivacaïne 0,5 %
Study: NCT02549144

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Low fat/cholesterol diet
Description: The low fat/cholesterol diet had 10% calories from fat and 150-200 mg of cholesterol per day.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: High fat/cholesterol diet
Description: The high fat/cholesterol diet had 40% calories from fat and 250-300 mg of cholesterol per day
Study: NCT02304094

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: methylprednisolone
Description: the steroid group shall receive a single injection of 1 mL methylprednisolone \[40 mg\] and 1 mL 2% lignocaine

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual manipulation
Description: the manipulation group shall have the lesser MTPJs of the affected foot manually manipulated using a high velocity, low amplitude thrust technique
Study: NCT04417491

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dry Needling
Description: Real dry needling will be conducted according to the fast-in and fast-out principle. The intervention will be applied until a total of four local twitch responses will be elicited
Study: NCT03969979

Intervention type: DIAGNOSTIC_TEST
Intervention: Shear wave elastography
Description: shear wave elastogrophy will be performed

Intervention type: DIAGNOSTIC_TEST
Intervention: Shear wave elastography
Description: shear wave elastogrophy will be performed
Study: NCT03914209

Intervention type: OTHER
Intervention: EHL clotting factor
Description: This study shall not implement any intervention that might alter the normal development of the daily life activities of hemophilia patients included in the study. They will continue with the prophylactic regimen prescribed by their hematologist. Patients will also be asked to continue to develop their physical, work, entertainment and leisure activities in the same way as at baseline.
Study: NCT01473589

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teriparatide
Description: Administered by SC injection

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered by SC injection

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Calcium supplementation
Description: Administered orally
Study: NCT04417491

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Needling
Description: Sham dry needling with be conducted with a sham needle device. This needle has a blunt tip and retractable handle that created the illusion of a needle penetrating the skin. When this needle touches the skin, a pricking sensation will be created. However, when pressure will be increased, the shaft of the needle disappears into the handle creating a sensation on the patient
Study: NCT03660956

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Twelves-week exercise training sessions include a variety of strength, flexibility, and coordination exercises. Each exercise session lasts for one hour. Participants are expected to attend exercise session once a week and are encouraged to continue exercising at home.
Study: NCT01473589

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Description: Administered orally
Study: NCT03660956

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Back counselling
Description: Procedure of back counselling includes one session back counselling, lasting one hour. The topics of back counselling session are as follows: (1) Anatomy of lumbar; (2) Factors causing low back pain; (3) Problems of physical inactivity for the lumbar; (4) Risk of poor postures for developing persistent/chronic low back pain; (5) Maintaining right posture of the lumbar; (6) Avoiding harmful loading of the back during work and leisure time.
Study: NCT01473589

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Vitamin D supplementation
Description: Administered orally

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Description: Administered orally
Study: NCT03074916

Intervention type: DEVICE
Intervention: DIP arthroplasty or arthrodesis
Description: Arthroplasty of the DIP Joint or arthrodesis of the DIP joint

Intervention type: DEVICE
Intervention: DIP arthroplasty or arthrodesis
Description: Arthroplasty of the DIP Joint or arthrodesis of the DIP joint